Abstract
Type 1 diabetes is a multi‐system disorder with immune‐mediated destruction of beta cells in the pancreatic islets. The resultant hyperglycaemia is responsible for clinical symptoms of the disease and causes a plethora of complications affecting both large and small blood vessels, known as macro and microvascular complications. As the key metabolic derangement in type 1 diabetes is hyperglycaemia, the core aim of medical management is to maintain glucose concentrations as near to the normal range as possible. In order to achieve this, a multidisciplinary team (MDT) approach is needed, with key roles played by dietitians, diabetes nurses and physicians, with patient education and empowerment as a cornerstone of disease management. Specific measures are advised to address the risk, including lifestyle modifications and pharmacological therapy. Hypoglycaemia is a common side‐effect of intensive glycaemic control in the context of type 1 diabetes.